The gene-editing treatment will be available to certain patients with sickle cell disease in England as Vertex commits to collecting additional data.

Billie Eilish and Green Day kicked off the FireAid benefit concert in Los Angeles on Thursday night - a two-venue, five-hour ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts ...

NHS officials estimate that around 50 people a year will receive treatment now that it has been approved for use for certain ...

The company will use the funding to advance clinical trials for Tune-401, the epigenetic silencing drug for treating chronic ...

Design Therapeutics' GeneTAC platform is revolutionizing genetic disease treatment with small molecules and promising results ...

Britain's National Health Service (NHS) will provide a cutting-edge gene therapy that aims to cure sickle cell disease, the ...

MaxCyte Inc., a leading cell therapy and gene editing company, announced Thursday that it has acquired SeQure Dx, a specialized gene editing firm, in a deal worth up to $7 million. The move is aimed ...

A gene-edited mouse with two male parents has survived to adulthood, pushing new progress on stem cell research.

(Alliance News) - MaxCyte Inc on Thursday said it has acquired SeQure Dx Inc, as it looks to improve its gene therapy testing process. The Rockville, Maryland-based cell therapy developer paid an ...